| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CETN2 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.008 |
| mRNA | FAM19A5 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.008 |
| mRNA | KRTAP29-1 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.008 |
| mRNA | LMO1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.008 |
| mRNA | PEX11A | CTRPv2 | pan-cancer | AAC | 0.4 | 0.008 |
| mRNA | ZC3H11A | CTRPv2 | pan-cancer | AAC | 0.31 | 0.008 |
| mRNA | VPS8 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.008 |
| mRNA | TXK | CTRPv2 | pan-cancer | AAC | -0.35 | 0.008 |
| mRNA | ARSD | CTRPv2 | pan-cancer | AAC | -0.32 | 0.008 |
| mRNA | PTDSS2 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.008 |
